pioglitazone tablet
1 INDICATIONS AND USAGE Monotherapy and Combination Therapy Pioglitazone tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings [see Clinical Studies (14) ] . Important Limitations of Use Pioglitazone tablets exert their antihyperglycemic effect only in the presence of endogenous insulin. Pioglitazone tablets should not be used to treat type 1 diabetes or diabetic ketoacidosis, as they would not be effective in these settings. Use caution in patients with liver disease [see Warnings and Precautions (5.3) ] . Pioglitazone tablets are a thiazolidinedione and an agonist for peroxisome proliferator-activated receptor (PPAR) gamma indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings. ( 1 , 14 ) Important Limitations of Use: • Not for treatment of type 1 diabetes or diabetic ketoacidosis. ( 1 )
mylan pharmaceuticals inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Pioglitazone Tablets, USP are available containing pioglitazone hydrochloride, USP equivalent to 15 mg, 30 mg or 45 mg of pioglitazone base. The 15 mg tablets are white to off-white, round, unscored tablets debossed with M over 48 on one side of the tablet and blank on the other side. They are available as follows: NDC 0378-0048-93 bottles of 30 tablets NDC 0378-0048-77 bottles of 90 tablets NDC 0378-0048-05 bottles of 500 tablets The 30 mg tablets are white to off-white, round, unscored tablets debossed with M over 228 on one side of the tablet and blank on the other side. They are available as follows: NDC 0378-0228-93 bottles of 30 tablets NDC 0378-0228-77 bottles of 90 tablets NDC 0378-0228-05 bottles of 500 tablets The 45 mg tablets are white to off-white, round, unscored tablets debossed with M over 318 on one side of the tablet and blank on the other side. They are available as follows: NDC 0378-0318-93 bottles of 30 tablets NDC 0378-0318-77 bottles of 90 tablets NDC 0378-0318-05 bottles of 500 tablets Storage: Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Keep container tightly closed, and protect from light, moisture and humidity. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. PHARMACIST: Dispense a Medication Guide with each prescription.
More pills like ROUND M 48